k. mccourt occupational therapy, p.c.

attn: kerry f. mccourt
20 huntington avenue
lynbrook, new york 11563

NYS Entity Status
ACTIVE

NYS Filing Date
SEPTEMBER 15, 2014

NYS DOS ID#
4636039

County
NASSAU

Jurisdiction
NEW YORK

Registered Agent
NONE

NYS Entity Type
DOMESTIC PROFESSIONAL CORPORATION

Name History
2014 - K. MCCOURT OCCUPATIONAL THERAPY, P.C.









Buffer



submit to reddit

Telephone
n/a

Fax
n/a

Website
n/a

Email address
n/a

LinkedIn
n/a

Facebook
n/a

Google+
n/a

Twitter
n/a

Pinterest
n/a

Instagram
n/a



  • Around the Web

  • DotCom Therapy Gets Shot at Silicon Valley VCs After Pitch Contest
    By Jeff Buchanan - Tuesday Aug 22, 2017

    DotCom Therapy, a Madison, WI-based startup that has developed software allowing the dozens of therapists it employs to provide remote speech therapy services to schoolchildren, captured first place in one of Wisconsin’s more closely watched pitch competitions on Monday. The contest DotCom Therapy won was the fourth annual “Pressure Chamber,” which is put on by […]

    Source: Xconomy VC, Deals, & Startups Feed
  • Report reveals years of suffering, death from therapies for “chronic Lyme”
    By Beth Mole - Friday Jun 16, 2017

    Coffee enemas, $13K “photon” therapy, endless antibiotics—all unproven, dangerous.

    Source: Ars Technica
  • Hiring a shrink could make your company more successful
    By Moneyish - Monday Sep 4, 2017

    This isn’t the kind of occupational therapy you’re used to. When Jonathan Pellegrin, the former chairman and CEO of publishing company Johnson Hill Press and author of “The Art of Selling the Family Business,” saw trouble brewing at his company, he knew just where to turn: a therapist specializing in workplace issues. With a history...

    Source: New York Post: Business
  • Destiny 2 on PC: 4K, GTX 1080 Ti, all the eye-candy
    By Mark Walton - Thursday Jun 15, 2017

    Sure, the Xbox One X and PS4 Pro support 4K too. But who wants to play at 30FPS?

    Source: Ars Technica
  • Stealthy NY Startup Rocket Pharma Merges With Inotek, Heads to Nasdaq
    By Ben Fidler - Tuesday Sep 12, 2017

    Rocket Pharmaceuticals, a stealthy gene therapy startup in New York City, has made its first splash. Through a merger with struggling Inotek Pharmaceuticals (NASDAQ: ITEK), Rocket, a company developing treatments for a variety of rare blood diseases, has taken itself public. Rocket shareholders are expected to own 81 percent of the combined company, with Inotek […]

    Source: Xconomy VC, Deals, & Startups Feed